Non-Thyroidal Illness in Chronic Renal Failure: Triiodothyronine Levels and Modulation of Extra-Cellular Superoxide Dismutase (ec-SOD)

Overview

Journal Antioxidants (Basel)

Date 2024 Jan 26

PMID 38275651

Authors

Antonio Mancini

Andrea Silvestrini

Fabio Marcheggiani

Emmanuele Capobianco

Sonia Silvestri

Erminia Lembo

Patrick Orlando

Flavia Beccia

Nicola Nicolotti

Nicola Panocchia

Luca Tiano

Affiliations

Soon will be listed here.

Abstract

Oxidative stress (OS) is implicated in several chronic diseases. Extra-cellular superoxide dismutase (ec-SOD) catalyses the dismutation of superoxide anions with a protective role in endothelial cells. In chronic kidney disease (CKD), OS and thyroid dysfunction (low fT3 syndrome) are frequently present, but their relationship has not yet been investigated. This cohort study evaluated ec-SOD activity in CKD patients during haemodialysis, divided into "acute haemodialytic patients" (AH, 1-3 months of treatment) and "chronic haemodialytic patients" (CH, treated for a longer period). We also evaluated plasmatic total antioxidant capacity (TAC) and its relationships with thyroid hormones. Two basal samples ("basal 1", obtained 3 days after the last dialysis; and "basal 2", obtained 2 days after the last dialysis) were collected. On the same day of basal 2, a sample was collected 5 and 10 min after the standard heparin dose and at the end of the procedure. The ec-SOD values were significantly higher in CH vs. AH in all determinations. Moreover, the same patients had lower TAC values. When the CH patients were divided into two subgroups according to fT3 levels (normal or low), we found significantly lower ec-SOD values in the group with low fT3 in the basal, 5, and 10 min samples. A significant correlation was also observed between fT3 and ec-SOD in the basal 1 samples. These data, confirming OS and low fT3 syndrome in patients with CKD, suggest that low fT3 concentrations can influence ec-SOD activity and could therefore potentially contribute to endothelial oxidative damage in these patients.

References

Fattman C, Schaefer L, Oury T . Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med. 2003; 35(3):236-56. DOI: 10.1016/s0891-5849(03)00275-2. View

Silvestrini A, Mordente A, Martino G, Bruno C, Vergani E, Meucci E . The Role of Selenium in Oxidative Stress and in Nonthyroidal Illness Syndrome (NTIS): An Overview. Curr Med Chem. 2018; 27(3):423-449. DOI: 10.2174/0929867325666180201111159. View

Fliers E, Boelen A . An update on non-thyroidal illness syndrome. J Endocrinol Invest. 2020; 44(8):1597-1607. PMC: 8285315. DOI: 10.1007/s40618-020-01482-4. View

Mancini A, Raimondo S, Di Segni C, Persano M, Gadotti G, Silvestrini A . Thyroid hormones and antioxidant systems: focus on oxidative stress in cardiovascular and pulmonary diseases. Int J Mol Sci. 2013; 14(12):23893-909. PMC: 3876084. DOI: 10.3390/ijms141223893. View

Huh J, Panagiotou G, Mougios V, Brinkoetter M, Vamvini M, Schneider B . FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012; 61(12):1725-38. PMC: 3614417. DOI: 10.1016/j.metabol.2012.09.002. View

Chopra I . Clinical review 86: Euthyroid sick syndrome: is it a misnomer?. J Clin Endocrinol Metab. 1997; 82(2):329-34. DOI: 10.1210/jcem.82.2.3745. View

Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, Hornig B . Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation. 2000; 101(19):2264-70. DOI: 10.1161/01.cir.101.19.2264. View

Hercbergs A, Mousa S, Davis P . Nonthyroidal Illness Syndrome and Thyroid Hormone Actions at Integrin αvβ3. J Clin Endocrinol Metab. 2018; 103(4):1291-1295. DOI: 10.1210/jc.2017-01939. View

Tan R, Zhou D, Xiao L, Zhou L, Li Y, Bastacky S . Extracellular Superoxide Dismutase Protects against Proteinuric Kidney Disease. J Am Soc Nephrol. 2015; 26(10):2447-59. PMC: 4587687. DOI: 10.1681/ASN.2014060613. View

10.

Montazerifar F, Hashemi M, Karajibani M, Sanadgol H, Dikshit M . Evaluation of lipid peroxidation and erythrocyte glutathione peroxidase and superoxide dismutase in hemodialysis patients. Saudi J Kidney Dis Transpl. 2012; 23(2):274-9. View

11.

Silvestrini A, Meucci E, Ricerca B, Mancini A . Total Antioxidant Capacity: Biochemical Aspects and Clinical Significance. Int J Mol Sci. 2023; 24(13). PMC: 10341416. DOI: 10.3390/ijms241310978. View

12.

Yamada H, Yamada Y, Adachi T, Fukatsu A, Sakuma M, Futenma A . Protective role of extracellular superoxide dismutase in hemodialysis patients. Nephron. 2000; 84(3):218-23. DOI: 10.1159/000045580. View

13.

De Groot L . Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006; 22(1):57-86, vi. DOI: 10.1016/j.ccc.2005.10.001. View

14.

Nakamura M, Ando Y, Sasada K, Haraoka K, Ueda M, Okabe H . Role of extracellular superoxide dismutase in patients under maintenance hemodialysis. Nephron Clin Pract. 2005; 101(3):c109-15. DOI: 10.1159/000086644. View

15.

Fukai T, Ushio-Fukai M . Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal. 2011; 15(6):1583-606. PMC: 3151424. DOI: 10.1089/ars.2011.3999. View

16.

Bossola M, Laudisio A, Antocicco M, Panocchia N, Tazza L, Colloca G . Intradialytic hypotension is associated with dialytic age in patients on chronic hemodialysis. Ren Fail. 2013; 35(9):1260-3. DOI: 10.3109/0886022X.2013.820645. View

17.

Qi X, Qiu L, Wang S, Chen X, Huang Q, Zhao Y . Non-thyroidal illness syndrome and the prognosis of heart failure: a systematic review and meta-analysis. Endocr Connect. 2023; 12(8). PMC: 10388663. DOI: 10.1530/EC-23-0048. View

18.

Miller N . Total antioxidant status in plasma and body fluids. Methods Enzymol. 1994; 234:279-93. DOI: 10.1016/0076-6879(94)34095-1. View

19.

Shimomura H, Maehata E, Takamiya T, Adachi T, Komoda T . Blood extracellular superoxide dismutase levels in hemodialysis patients pre- and post-hemodialysis and its association with lipoprotein lipase mass and free fatty acid. Clin Chim Acta. 2003; 328(1-2):113-9. DOI: 10.1016/s0009-8981(02)00378-9. View

20.

Marklund S, Holme E, Hellner L . Superoxide dismutase in extracellular fluids. Clin Chim Acta. 1982; 126(1):41-51. DOI: 10.1016/0009-8981(82)90360-6. View